ACE2 and COVID-19: Zhou et al38 and Hoffmann et al4 identified ACE2 as a major receptor of COVID‐19,4, 38, 39 and these findings suggest that understanding ACE2‐positive cells should be key for improving the treatment and prognosis of patients with COVID‐19.